Stanley, T
Safety Considerations and Who Should Monitor More Closely Women with polycystic ovary syndrome (PCOS), endometriosis, or dysmenorrhea already experience dysregulated hormonal cycles and heightened GI sensitivity
GLP-1 medications, integral to our Medical Weight Loss program, have shown remarkable results in aiding weight loss in individuals with obesity or weight management challenges
In addition, murine models show that liraglutide can access specific brain areas relevant for appetite regulation, binding GLP-1 receptors on proopiomelanocortin and cocaine- and amphetamine-regulated transcript (POMC/CART)-expressing arcuate nucleus neurons [32]
But the BBB tells a different story: an F rating for failing to respond to 9 out of 11 filed complaints
(A head-to-head trial of the two medications, funded by Eli Lilly, found that patients on Zepbound lost an average of 20 percent of their weight, versus about 14 percent for those on Wegovy.) Nevertheless, its much harder to get Zepbound than Wegovy